{
  "id": 1982383,
  "title": "Moderna and Merck Just Made History With the First mRNA Cancer Vaccine to Succeed in a Phase 3 Trial. Here's What That Means for Investors.",
  "url": "https://urgent.news/2026/08/19/moderna-and-merck-just-made-history-with-the-first-mrna-cancer",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-19T16:34:01.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/08/19/moderna-and-merck-just-made-history-with-the-first-mrna-cancer-vaccine-to-succeed-in-a-phase-3-trial-heres-what-that-means-for-investors/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": null,
  "summary": "The treatment combines an mRNA shot with Merck's Keytruda.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 11,
    "also_reported_by": [
      {
        "outlet": "STAT News",
        "title": "STAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial",
        "url": "https://urgent.news/2026/08/19/stat-moderna-and-merck-say-mrna-cancer-vaccine-succeeded-in-late",
        "published": "2026-08-19T10:45:00.000Z"
      },
      {
        "outlet": "Endpoints News",
        "title": "Merck, Moderna declare Phase 3 success for personalized mRNA cancer vaccine",
        "url": "https://urgent.news/2026/08/19/merck-moderna-declare-phase-3-success-for-personalized-mrna-cancer",
        "published": "2026-08-19T10:45:01.000Z"
      },
      {
        "outlet": "CNBC World",
        "title": "Personalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trial",
        "url": "https://urgent.news/2026/08/19/personalized-cancer-vaccine-from-moderna-merck-shows-promise-in-first",
        "published": "2026-08-19T10:49:31.000Z"
      },
      {
        "outlet": "Quartz",
        "title": "Moderna and Merck's personalized skin cancer vaccine cleared its first large-scale trial",
        "url": "https://urgent.news/2026/08/19/moderna-and-mercks-personalized-skin-cancer-vaccine-cleared-its-first",
        "published": "2026-08-19T11:40:44.000Z"
      },
      {
        "outlet": "Financial Times",
        "title": "Moderna share price doubles on melanoma vaccine trial success",
        "url": "https://urgent.news/2026/08/19/moderna-share-price-doubles-on-melanoma-vaccine-trial-success",
        "published": "2026-08-19T12:08:31.000Z"
      },
      {
        "outlet": "Bloomberg",
        "title": "Merck, Moderna Melanoma Vaccine Study Succeeds",
        "url": "https://urgent.news/2026/08/19/merck-moderna-melanoma-vaccine-study-succeeds",
        "published": "2026-08-19T13:41:45.000Z"
      },
      {
        "outlet": "The Hill",
        "title": "Moderna, Merck mRNA cancer vaccine prevents melanoma from returning",
        "url": "https://urgent.news/2026/08/19/moderna-merck-mrna-cancer-vaccine-prevents-melanoma-from-returning",
        "published": "2026-08-19T14:54:50.000Z"
      },
      {
        "outlet": "CBC News",
        "title": "Merck and Moderna say mRNA melanoma vaccine hits goals in late-stage trial",
        "url": "https://urgent.news/2026/08/19/merck-and-moderna-say-mrna-melanoma-vaccine-hits-goals-in-late-stage",
        "published": "2026-08-19T15:31:25.000Z"
      },
      {
        "outlet": "The New York Times",
        "title": "Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning",
        "url": "https://urgent.news/2026/08/19/moderna-merck-say-mrna-vaccine-prevents-melanoma-from-returning",
        "published": "2026-08-19T15:37:24.000Z"
      },
      {
        "outlet": "Nasdaq Markets",
        "title": "Moderna and Merck Just Made History With the First mRNA Cancer Vaccine to Succeed in a Phase 3 Trial. Here's What That Means for Investors.",
        "url": "https://urgent.news/2026/08/19/moderna-and-merck-just-made-history-with-the-first-mrna-cancer-1984332",
        "published": "2026-08-19T16:54:01.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}